Join
Live feed
·
SECFilingvia Quantisnow
Spero Therapeutics Inc. logo

Spero Therapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
SPRO· Spero Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRO (Spero Therapeutics Inc.) and more on Quantisnow.